Pacific Biosciences of California (STU:P09) Institutional Ownership: 42.32% (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:P09 Pacific Biosciences of California Inc STU:P09
59 GF Score
Price €1.19
GF Value €1.42
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Institutional Ownership?

Pacific Biosciences of California STU:P09 +1.02% 59 Institutional Ownership is 42.32% as of Jul. 28, 2026. GuruFocus rates STU:P09 with a GF Score™ of 59/100 and a GF Value™ of €1.42 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pacific Biosciences of California's institutional ownership is 42.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pacific Biosciences of California's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pacific Biosciences of California's Float Percentage Of Total Shares Outstanding is 86.98%.

Pacific Biosciences of California Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Institutional Ownership Chart

Pacific Biosciences of California Historical Data

The historical data trend for Pacific Biosciences of California can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 43.35 45.37 45.31 46.66 46.91 47.28 47.09 45.08 44.24 42.32
STU:P09
59GF Score
Pacific Biosciences of California Inc STU:P09
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 42.32% mean?
Pacific Biosciences of California (STU:P09) has a Institutional Ownership of 42.32% as of Jul. 28, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's Institutional Ownership too high?
Pacific Biosciences of California's current Institutional Ownership is 42.32%. Overall, Pacific Biosciences of California has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Institutional Ownership compare to DCTH and CLPT?
Pacific Biosciences of California's Institutional Ownership of 42.32% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current Institutional Ownership is 42.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Based on GuruFocus' analysis, Pacific Biosciences of California (STU:P09) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.42, compared to a current price of €1.19 — trading 16% below its estimated fair value. The current Institutional Ownership is 42.32%. Pacific Biosciences of California's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Pacific Biosciences of California (STU:P09), the current Institutional Ownership is 42.32% as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (STU:P09) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued. The current stock price of €1.19 is trading 16% below its estimated GF Value™ of €1.42. GuruFocus considers Pacific Biosciences of California to be Modestly Undervalued.

Key valuation signals for STU:P09:

  • Institutional Ownership: 42.32%
  • GF Value™: €1.42 vs. price of €1.19 (16% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the STU:P09 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges PACB:USA
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
59GF Score

Get the complete analysis for STU:P09

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.19
Price
€1.42
GF Value